MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo (Q38431323)
Jump to navigation
Jump to search
scientific article published on 22 June 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo |
scientific article published on 22 June 2010 |
Statements
1 reference
MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo (English)
1 reference
Hiroshi Hirai
1 reference
Hiroshi Sootome
1 reference
Yoko Nakatsuru
1 reference
Katsuyoshi Miyama
1 reference
Shunsuke Taguchi
1 reference
Kyoko Tsujioka
1 reference
Yoko Ueno
1 reference
Harold Hatch
1 reference
Pradip K Majumder
1 reference
Bo-Sheng Pan
1 reference
Hidehito Kotani
1 reference
22 June 2010
1 reference
1 reference
Identifiers
1 reference